Alkermes, Inc. ALKS today announced the initiation of a phase 3 clinical trial of VIVITROL ® (naltrexone for extended-release injectable suspension) for the treatment of opioid dependence. The multi-center study is designed to assess the efficacy ...
Original post: Alkermes Initiates Phase 3 Clinical Study of VIVITROL(R) for the ... - MSN MoneyCentral
- Recent posts
- Pain management and procedural sedation handbook / W. James ...
- Alkermes Initiates Phase 3 Clinical Study of VIVITROL(R) for the ... - MSN MoneyCentral
- Pain Management
- Adjuvant Informatics
- Golf comes up aces: Tiger, Rocco save world of sports - ESPN.com
- Jamestown Man Earns Medical Degree - Post-Journal
- What to expect from Pain Management Dr.?
- All Natural Pain Management Techniques
- Oridion Announces Major Medical Research and Congress Presentations - Forbes
- A little of this, a little of that
- New plans to tackle chronic pain - BBC UK News
- Texas Tech Annual Pain Symposium brings experts from around the world - U-Wire.com
- BlueChoice HealthPlan to Launch Back Care Program - dBusinessNews.com
- Entereg (alvimopan) Available for the Management of Postoperative ... - Phramalive.com
- New tests help keep health-care management closer to home - Chicago Tribune
- Curlin Medical Awarded Three-Year Pain Management - Local ...
- Corporate Social Responsibility - CSR Wire
- The Jury Is Still Out On How Best To Treat Chronic Pain - Medical News Today
- Accidental Extra Strength Morphine
- Pain Management in Veterinary Medicine